Pre-Pregnancy Weight Loss and Baby Behavior Study
Launched by UNIVERSITY OF MICHIGAN · Apr 5, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The researchers will recruit babies from the original cohort in the PLAN study (NCT03244722), regardless of which arms they participated in. However, the researchers will test the study arms from the original PLAN study for effects on the study's dependent variables. Their between-subjects arms included Pre-pregnancy obesity with intensive weight loss intervention, pre-pregnancy obesity with standard of care intervention, and pre-pregnancy healthy weight with no intervention. So, although the researchers are not assigning babies to any arms, their original assignment will still be assessed ...
Gender
ALL
Eligibility criteria
- • To be eligible to participate in this study...
- • Mother
- • -Current or previous participation in the PLAN study resulting in a live birth.
- • Child
- • Mother participated in PLAN study during child's gestation
- • Infant birth weight (From PLAN study records) appropriate (≥ 3rd percentile and ≤ 97th percentile) for gestational age and sex based on US Natality Data set (Oken et al, BMC Pediatrics 2003).
- • Infant is 3.0 to 6.0 months old at Consent.
- • Biological mother is legal guardian by maternal report.
- • Biological mother is full time custodial guardian by maternal report (versus sharing custody such that infant does not live with her full time).
- • Infant typically consumes at least 2 ounces in one feeding from an artificial nipple and bottle at least once per week by maternal report.
- • Stated willingness by mother to comply with all study procedures and availability for the duration of the study.
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Patients applied
Trial Officials
Amanda Crandall, PhD
Principal Investigator
University of Michigan
Julie Lumeng, MD
Principal Investigator
University of Michigan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported